Joseph B. Saluri
Mr. Saluri has served as a director of Zevra Therapeutics (then KemPharm, Inc.) since January 2014. Mr. Saluri currently serves as chief executive officer and chairman of the board of BlueAllele, LLC, a start-up biotechnology company located in Oakdale, Minnesota.
Mr. Saluri previously served as general counsel and executive vice president for Calyxt, Inc. from June 2017 to March 2018. Prior to his employment with Calyxt, Inc., Mr. Saluri served as general counsel for Stine Seed Company and its affiliates from July 1999 to March 2017.
Mr. Saluri practiced as an attorney and solicitor at law with Nicholas Critelli Associates, PC, in Des Moines, Iowa and London, England from June 1993 to June 1999. Mr. Saluri served as a director of Newlink Genetics Corporation, a public biopharmaceutical company from May 2010 to July 2017.
Mr. Saluri received his juris doctorate from Drake University Law School and his Bachelor of Science in business administration from Drake University.